Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.82 is 65% below its 5-year average of 2.33, near the low end of its 5-year range (0.23–14.73).
As of the fiscal period ended Tuesday, June 30, 2026. 19.89% above its 12-month average of 0.68.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.82.
QUICK RATIO (ACID-TEST)
0.82
QUICK RATIO (ACID-TEST) AVG TTM
0.68
QUICK RATIO (ACID-TEST) AVG 3Y
0.75
QUICK RATIO (ACID-TEST) AVG 5Y
2.33
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.89%
CURRENT VS 3Y AVG
+8.78%
CURRENT VS 5Y AVG
-64.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 613 covered companies
CURRENT VS SECTOR MEDIAN
-72.62%
vs the sector median at left
Market Cap
$2.73M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.70
3Y Avg
0.81
5Y Avg
0.98
Market Cap
$2.55M
Quick Ratio (Acid-Test)
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.49M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$2.43M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.19
3Y Avg
3.93
5Y Avg
6.93
Market Cap
$2.32M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.94M
Quick Ratio (Acid-Test)
1.15
TTM Avg
2.58
3Y Avg
1.43
5Y Avg
2.20
Market Cap
$2.94M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.91
3Y Avg
2.68
5Y Avg
12.13
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.62M | 0.82 | 0.68 | 0.75 | 2.33 |
| Jaguar Health, Inc. (JAGX)vs › | $2.73M | 0.40 | 0.70 | 0.81 | 0.98 |
| Nuwellis, Inc. (NUWE)vs › | $2.55M | 1.54 | 1.94 | 2.53 | 3.69 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.55M | 2.64 | 2.37 | 1.52 | 1.27 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.49M | 1.41 | 1.72 | 3.92 | 2.64 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | 0.94 | 1.19 | 3.93 | 6.93 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.73 | 22.34 | 19.49 | 14.70 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.94M | 1.15 | 2.58 | 1.43 | 2.20 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $2.94M | 2.35 | 1.91 | 2.68 | 12.13 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.21M | 1.54 | 2.65 | 3.41 | 4.73 |
Quick Ratio
0.82
Excludes inventory
Current Ratio
0.82
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.82 |
| 2026-03-31 | 0.62 |
| 2025-12-31 | 1.12 |
| 2025-09-30 | 0.63 |
| 2025-06-30 | 0.23 |
| 2025-03-31 | 0.31 |
| 2024-12-31 | 0.62 |
| 2024-09-30 | 0.74 |
| 2024-06-30 | 0.90 |
| 2024-03-31 | 0.93 |
| 2023-12-31 | 1.36 |
| 2023-09-30 | 2.59 |
| 2023-06-30 | 3.84 |
| 2023-03-31 | 4.14 |
| 2022-12-31 | 4.60 |
| 2022-09-30 | 8.55 |
| 2022-06-30 | 13.37 |
| 2022-03-31 | 14.73 |
| 2021-12-31 | 13.15 |
| 2021-09-30 | 7.09 |
| 2021-06-30 | 2.86 |
| 2021-03-31 | 0.12 |
| 2020-12-31 | 0.16 |
| 2020-09-30 | 0.16 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.10 |
| 2019-09-30 | 0.00 |
